For a patient undergoing open appendectomy who is on telmisartan 40 mg once daily, carvedilol 12.5 mg once daily, metformin 500 mg once daily for diabetes mellitus, and levothyroxine 50 µg once daily for hypothyroidism, how should these medications be managed peri‑operatively?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Perioperative Medication Management for Open Appendectomy

Continue telmisartan, carvedilol, and levothyroxine on the morning of surgery; hold metformin on the day of surgery and restart when oral intake resumes. 1

Telmisartan (ARB) - Hold on Day of Surgery

While there is ongoing debate about ARB management, the safest approach is to hold telmisartan on the morning of surgery due to increased risk of intraoperative hypotension. ARBs and ACE inhibitors are the two exceptions to the general rule of continuing antihypertensives perioperatively 2. The drug label confirms telmisartan can cause symptomatic hypotension in volume-depleted states, which commonly occur during surgery 3.

  • Restart telmisartan within 24-48 hours postoperatively once hemodynamically stable and oral intake established 4
  • Monitor blood pressure closely during the perioperative period
  • Ensure adequate volume status before anesthesia induction

Carvedilol (Beta-blocker) - Continue

Continue carvedilol 12.5 mg on the morning of surgery with a sip of water. This patient is already on chronic beta-blocker therapy, and abrupt discontinuation increases risk of rebound hypertension, tachycardia, and myocardial ischemia 1. The 2024 AHA/ACC guidelines emphasize that patients already taking beta-blockers should continue them perioperatively 1.

  • The FDA label notes that if carvedilol is continued perioperatively, use caution with myocardial-depressant anesthetic agents 5
  • Critical pitfall: Never initiate beta-blockers <7 days before surgery (associated with increased mortality), but this patient is already on chronic therapy 1
  • Resume normal dosing schedule postoperatively

Metformin - Hold Day of Surgery

Hold metformin 500 mg on the day of surgery. The 2024 AHA/ACC guidelines state that continuation of metformin during the perioperative period is reasonable for glycemic control 1, but the practical approach for appendectomy (which may involve NPO status and potential bowel involvement) is to hold it the morning of surgery.

  • Restart metformin when patient resumes normal oral intake and renal function is confirmed stable (typically postoperative day 1-2 for uncomplicated appendectomy)
  • Check renal function if not done within 3 months 1
  • Monitor for lactic acidosis risk factors (sepsis, hypoperfusion)
  • Important: If patient were on SGLT2 inhibitors, those must be stopped 3-4 days before surgery to prevent perioperative ketoacidosis 1, but metformin does not carry this risk

Levothyroxine - Continue

Continue levothyroxine 50 mcg on the morning of surgery with a sip of water. Thyroid hormone has a long half-life (approximately 7 days), so missing a single dose has minimal clinical impact, but there is no reason to hold it 6.

  • Resume normal dosing schedule immediately postoperatively
  • Inadequately controlled hypothyroidism is associated with increased cardiovascular risk in diabetic patients 6
  • No dose adjustment needed for surgery itself

Additional Perioperative Considerations

Glycemic monitoring: Check HbA1c if not done within 3 months 1. Target intraoperative glucose control, though optimal targets remain undefined 1.

Drug interactions: Monitor digoxin levels if patient is on it (carvedilol increases digoxin by 15%) 5. Carvedilol may enhance blood-sugar-lowering effects of metformin, requiring closer glucose monitoring 5.

Anesthesia coordination: Inform anesthesiologist about carvedilol continuation, as it may interact with myocardial-depressant anesthetic agents 5.

Blood pressure management: Expect potential hypotension from combined effects of ARB withdrawal, beta-blockade, and anesthesia. Have vasopressors readily available.

Related Questions

Why is telmisartan (an angiotensin‑II receptor blocker) withheld on the day of surgery?
In a 68-year-old woman with hypertension and stage 3 chronic kidney disease who is taking lisinopril and metoprolol and has a pre‑operative blood pressure of 178/104 mm Hg without chest pain or other acute findings, what is the most appropriate step to manage her elevated blood pressure before surgery?
In a 70-year-old man with hypertension treated with losartan and pre‑diabetes undergoing elective total knee arthroplasty, should he continue his home losartan, replace it with carvedilol (Coreg) during the peri‑operative period, or continue losartan and add carvedilol?
Is it safe to continue metformin in a patient with type 2 diabetes and hypothyroidism, and how should levothyroxine be timed?
What are the pre‑operative guidelines for continuing atenolol (beta‑blocker) on the day of surgery, including monitoring and criteria for withholding the dose?
Is it reasonable to restart Zopiclone (zopiclone) after discontinuation?
Can prolonged fasting precipitate gallstone formation?
How should nattokinase and serrapeptase be combined safely, including recommended dosing, timing, contraindications, and monitoring?
Do the service‑recorded patellofemoral pain/arthralgia (on the listed dates) and chronic right‑knee pain provide a medical nexus to the veteran’s current left‑knee lateral‑facet patellofemoral osteoarthritis, and is the veteran’s lay statement of continuous left‑knee symptoms since [YEAR] considered credible in supporting a ‘Yes’ nexus conclusion?
Is it safe to restart zopiclone in a 64-year-old patient with an implantable cardioverter-defibrillator who has been off the drug for two months after more than 20 years of use?
What are the specific reversal agents for each direct oral anticoagulant (DOAC) and the alternative non‑specific options for managing bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.